DiaMedica Therapeutics
DMAC
DMAC
15 hedge funds and large institutions have $3.91M invested in DiaMedica Therapeutics in 2019 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
40% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 5
Holders
15
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$49K | |
| 2 | +$31.3K | |
| 3 | +$28.1K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$10.4K |
| 5 |
PFGIA
Patriot Financial Group Insurance Agency
Westborough,
Massachusetts
|
+$3.54K |
Top Sellers
| 1 | -$184K | |
| 2 | -$184K | |
| 3 | -$95.4K | |
| 4 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$28K |
| 5 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
-$27K |